Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Drug development in spinal cord injury: What is the FDA looking for?
Edward D. Hall
Neuroscience
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug development in spinal cord injury: What is the FDA looking for?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
21 Aminosteroid
11%
Animal
11%
Antioxidant
11%
Complication
11%
Drug
11%
Drug Development
100%
Glucocorticoid
22%
Human
11%
Injury
22%
Lipid
22%
Methylprednisolone
55%
Neuroprotective Agent
11%
Oxygen
11%
Spinal Cord Injury
100%
Tirilazad
22%
Biochemistry, Genetics and Molecular Biology
Animal Models
11%
Development
100%
Drug Dose Regimen
11%
Drug Megadose
33%
Glucocorticoid
22%
Human
11%
Lipid Peroxidation
22%
Methylprednisolone
55%
Regulatory Mechanism
11%
Steroid
11%
Tirilazad
22%
Neuroscience
21 Aminosteroid
11%
Lipid Peroxidation
22%
Methylprednisolone
55%
Neuroprotective Agent
11%
Spinal Cord
22%
Spinal Cord Injury
100%
Veterinary Science and Veterinary Medicine
Glucocorticoid
22%
Methylprednisolone
55%
Spinal Cord Injury
100%